Wednesday, November 17, 2021
Print Current Session:
|
|
Wednesday
SESSION 31:
ADVANCES IN MEDICAL TREATMENTS, NEW ANTI-ATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
|
|
SESSION 31 SCHEDULE | |
6:40 AM - 6:45 AM | What Adequate And Ideal Lipid Levels Should We Strive For In PAD Patients: How To Get There |
Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom West, 3rd Floor |
|
6:46 AM - 6:51 AM | When, Why And How To Lower High Triglyceride Levels: Value Of Vascepa To Decrease Cardiac Risk In Vascular Patients: Based On The REDUCE-IT RCT |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC Location: Grand Ballroom West, 3rd Floor |
|
6:52 AM - 6:57 AM | Risks And Consequences Of Perioperative Myocardial Infarctions (MIs) In Open Vascular Surgery Patients: What Can Be Done To Decrease MI Incidence And Their Morbidity And Mortality When They Occur |
Presenter(s):Peter Henke, MD Location: Grand Ballroom West, 3rd Floor |
|
6:58 AM - 7:03 AM | Update On LDL-C Lowering During A Lifetime: How Low To Strive For; How Young To Start If High; How Old To Continue Statins |
Presenter(s):J. David Spence, MD Location: Grand Ballroom West, 3rd Floor |
|
7:04 AM - 7:09 AM | DEBATE: LDL-C Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful |
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC Location: Grand Ballroom West, 3rd Floor |
|
7:10 AM - 7:15 AM | DEBATE: Not So: LDL-C Lowering With Statins And Other Drugs Stabilizes And Shrinks Plaques And Decreases Morbid Vascular Events: Stopping Statins Increases Patients’ Risk Of MI And Death |
Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor |
|
7:16 AM - 7:21 AM | Low Dose Rivaroxaban (Bayer) And Aspirin Improve Survival And Decrease Major Adverse Limb Events (MALE) After Endo and Open Treatments For PAD/CLTI: From The VOYAGER RCT |
Presenter(s):Sebastian E. Debus, MD, PhD / Marianne Brodmann, MD Location: Grand Ballroom West, 3rd Floor |
|
7:22 AM - 7:27 AM | How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And Compass Trials |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC Location: Grand Ballroom West, 3rd Floor |
|
7:28 AM - 7:33 AM | New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimbe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For |
Presenter(s):Richard Bulbulia, MA, MD, FRCS Location: Grand Ballroom West, 3rd Floor |
|
7:34 AM - 7:42 AM | Panel Discussion |
END OF SESSION 31 | |
previous | next |